Needham & Company Maintains a 'Buy' on Brooks Automation (BRKS); Weak F4Q11 Results and Guidance as Expected, but Life Science Effort Taking Shape

Needham & Company maintains a 'Buy' on Brooks Automation Inc. (NASDAQ: BRKS) price target cut $1 to $12.

Needham analyst says, "BRKS reported F4Q11 (Sep) results at below consensus estimates, and provided weaker guidance as we had previewed. Near-term headwinds in multiple end markets are impacting BRKS’s core business, but the new compound sampling life science business is starting to deliver growth as the company integrates the two acquisitions. The depressed earnings in FY2012 reflect the time BRKS will need to complete its strategic efforts to drive higher growth and margin improvements. However, we like its long-term growth potential and therefore maintain our Buy...We lower FY12 EPS to $0.55 and FY13 to $0.92 but keep our revenue estimates unchanged."

For an analyst ratings summary and ratings history on Brooks Automation Inc. click here. For more ratings news on Brooks Automation Inc. click here.

Shares of Brooks Automation Inc. closed at $10.01 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Quanterix Corp. (QTRX) PT Lowered to $3 at Canaccord
• HomeTrust to acquire Blue Ridge Bankshares in $448M all-stock deal